Atlas Trials

Evaluation of the Role of miR-1 in the Pathogenesis and as a Biomarker in Muscular Dystrophies and Congenital Myopathies

Clinical trial NCT07415837 · RECRUITING

Trial details

NCT number
NCT07415837
Sponsor
University Hospital, Clermont-Ferrand
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Duchenne / Becker Muscular DystrophyDystrophia Myotonica 1Congenital MyopathiesHealthy Participants
Start date
2026-02-11
Primary completion
2029-03-01
Enrollment
104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.